Search results
Results from the WOW.Com Content Network
The treatment is a type of metabolic therapy that has no evidence of efficacy. [47] Hoxsey therapy – a treatment consisting of a caustic herbal paste for external cancers or a herbal mixture for "internal" cancers, combined with laxatives, douches, vitamin supplements and dietary changes. A review by the Memorial Sloan Kettering Cancer Center ...
Lomustine is an alkylating chemotherapy drug that is indicated by the FDA for the treatment of patients with brain tumors (primary and metastatic), following any necessary surgery and radiation, as well as for treatment of progressive Hodgkin’s lymphoma. [8]
Barbara O'Neill (born 28 July 1953 [1]) is an Australian alternative health care promoter who advertises unsupported health practices described as misinformation and a risk to health and safety by the New South Wales Health Care Complaints Commission.
Lemons have long been considered a superfood for their extensive health benefits and varied recipe uses. Not only are they one of the most popular citrus fruits, but lemons are a good source of ...
Ashley Anne Kirilow (born 1987) is a Canadian woman who raised money to aid cancer patients while pretending to have cancer herself. [1] [2] When Kirilow's fraud was made public, her story was republished around the world. [3]
In phase 3 clinical trials, patients with non-small cell lung cancer received Lumakras or intravenous chemotherapy (docetaxel). The patients may have tried other treatments like immunotherapy.
At its peak, Fata's practice was treating 17,000 patients at its clinics. Fata acquired a sterling reputation as one of the best cancer specialists in the Detroit area. He was known for his aggressive approach to treatment, giving higher doses of chemotherapy drugs at a more frequent rate—a protocol he called "European protocol". [1]
Mesna is used therapeutically to reduce the incidence of haemorrhagic cystitis and haematuria when a patient receives ifosfamide or cyclophosphamide for cancer chemotherapy. These two anticancer agents, in vivo , may be converted to urotoxic metabolites, such as acrolein .